Three high throughput compatible cell-based assays for identifying small molecule JAG1 upregulators for Alagille syndrome
Molly R. Kulikauskas(University of North Carolina at Chapel Hill), Catherine Z. Chen(National Institutes of Health), Karsten Baumgaertel(Therapeutics Clinical Research), Wei Zheng(Liaoning Cancer Hospital & Institute), Phillip R. Sanchez(National Institutes of Health), Atena Farkhondeh(National Institutes of Health), Ivan Pavlinov(National Institutes of Health), Dvir Blivis(National Institutes of Health), Xiuli Huang, Guibin Chen(National Institutes of Health), Ty Voss(National Institutes of Health), Steve Rodems(Therapeutics Clinical Research)
Cited by 0
Related Papers
Human Pluripotent Stem Cell-Derived Neural Cells and Brain Organoids Reveal SARS-CoV-2 Neurotropism Predominates in Choroid Plexus Epithelium
|Cell stem cell|2020|460
Inhibition of the Mitochondrial Protease ClpP as a Therapeutic Strategy for Human Acute Myeloid Leukemia
|Cancer Cell|2015|348
Identification of 53 compounds that block Ebola virus-like particle entry via a repurposing screen of approved drugs
|Emerging Microbes & Infections|2014|242
Identification of SARS-CoV-2 3CL Protease Inhibitors by a Quantitative High-Throughput Screening
|ACS Pharmacology & Translational Science|2020|225